Remember meForgot password?
    Log in with Twitter
Press Release

Xarelto Lawsuits Continue To Be Filed While FDA Issues Black Box Warnings About Risks Of Excessive Bleeding reports on the death of a Xarelto user who suffered a subdural hemorrhage due to uncontrollable internal bleeding that doctors were unable to stop. His widow alleges the fatal bleed was caused by taking Xarelto, a blood-thinning drug manufactured by Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer Healthcare.

The widow has filed a lawsuit against the makers of the drug claiming that they did not sufficiently warn consumers about the dangerous bleeding risks associated with the drug. Her case was originally filed in the State of Florida but is now part of the 2,800 cases that have been consolidated by a decision of the U.S. Judicial Panel on Multidistrict Litigation (JPML). The multidistrict litigation (MDL 2592) cases are being overseen in federal court in the Eastern District of Louisiana under the administrative hand of Judge Eldon Fallon.

In addition to the cases encompassed in the MDL, there are 550 more cases that the Court of Common Pleas in Philadelphia, Pennsylvania has consolidated in a mass tort program.

The U.S. Food and Drug Administration approved and released Xarelto to the consumer market in 2011. It was at the time touted as a new-generation blood-thinning drug since it was unlike its predecessor drugs in that patients no longer had to follow strict, special diets nor did they have to be continually monitored by medical professionals. Unfortunately, this excitement over the drug and its benefits may have initially overshadowed the dangerous risks associated with it. Today, however, many plaintiffs have filed lawsuits against the manufacturers of the drug alleging that it has dangerous and life-threatening risks to patients taking it. The FDA seems to concur since it has issued two black box warnings against Xarelto. Black box warnings are extremely serious and many times are a precursor to the drug being taken off the market.

The attorneys of Banville Law, the firm behind, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.



Banville Law
165 West End Ave #1h, New York, NY 10023

Latest News
Top News